DK1961423T3 - Anvendelse af pneumocytter af type II ved behandling af lungesygdomme i forbindelse med lungefibrose - Google Patents

Anvendelse af pneumocytter af type II ved behandling af lungesygdomme i forbindelse med lungefibrose

Info

Publication number
DK1961423T3
DK1961423T3 DK06841789.8T DK06841789T DK1961423T3 DK 1961423 T3 DK1961423 T3 DK 1961423T3 DK 06841789 T DK06841789 T DK 06841789T DK 1961423 T3 DK1961423 T3 DK 1961423T3
Authority
DK
Denmark
Prior art keywords
pneumocytes
treatment
type
pulmonary fibrosis
pulmonary
Prior art date
Application number
DK06841789.8T
Other languages
English (en)
Inventor
Mollar Ana Maria Serrano
Autet Daniel Closa
Moreu Jose Oriol Bulbena
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Application granted granted Critical
Publication of DK1961423T3 publication Critical patent/DK1961423T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06841789.8T 2005-11-28 2006-11-27 Anvendelse af pneumocytter af type II ved behandling af lungesygdomme i forbindelse med lungefibrose DK1961423T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200502939A ES2308877B1 (es) 2005-11-28 2005-11-28 Empleo de nuemocitos tipo ii en el tratamiento de enfermedades pulmonares que cursan con fibrosis pulmonar.
PCT/ES2006/070182 WO2007060278A1 (es) 2005-11-28 2006-11-27 Empleo de neumocitos tipo ii en el tratamiento de enfermedades pulmonares que cursan con fibrosis pulmonar

Publications (1)

Publication Number Publication Date
DK1961423T3 true DK1961423T3 (da) 2012-06-25

Family

ID=38066937

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06841789.8T DK1961423T3 (da) 2005-11-28 2006-11-27 Anvendelse af pneumocytter af type II ved behandling af lungesygdomme i forbindelse med lungefibrose

Country Status (11)

Country Link
US (1) US9610305B2 (da)
EP (1) EP1961423B1 (da)
JP (1) JP5702521B2 (da)
AT (1) ATE550027T1 (da)
BR (1) BRPI0619353A2 (da)
CA (1) CA2631172C (da)
DK (1) DK1961423T3 (da)
ES (2) ES2308877B1 (da)
PL (1) PL1961423T3 (da)
PT (1) PT1961423E (da)
WO (1) WO2007060278A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2972226A1 (en) * 2014-12-24 2016-06-30 Ube Industries, Ltd. Cell culture supernatant fluid derived from lung tissue

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609412B2 (en) * 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US20020164790A1 (en) 1999-12-07 2002-11-07 David Warburton Lung stem cells and lung regeneration
US7211247B2 (en) 2001-04-09 2007-05-01 University Of Southern California Lentivirus vectors for gene transfer to alveolar epithelial cells
GB0218332D0 (en) * 2002-08-07 2002-09-18 Imp College Innovations Ltd Preparation of type pneumocytes
CA2535683A1 (en) * 2003-08-11 2005-02-24 University Of South Florida Stem cell beacon
WO2005040391A1 (en) * 2003-10-27 2005-05-06 Murdoch Childrens Research Institute Compositions and methods for differentiating stem cells
EP1548100A1 (en) * 2003-11-11 2005-06-29 DeltaCell B.V. Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by Wnt factors
ATE512212T1 (de) 2004-04-21 2011-06-15 Univ Minnesota Erzeugung von lungengewebe aus multipotenten adulten progenitorzellen (mapc)

Also Published As

Publication number Publication date
ES2308877B1 (es) 2009-10-26
CA2631172C (en) 2014-08-05
JP2009517372A (ja) 2009-04-30
CA2631172A1 (en) 2007-05-31
ATE550027T1 (de) 2012-04-15
ES2384564T3 (es) 2012-07-09
PT1961423E (pt) 2012-06-28
EP1961423B1 (en) 2012-03-21
US20090220467A1 (en) 2009-09-03
ES2308877A1 (es) 2008-12-01
JP5702521B2 (ja) 2015-04-15
US9610305B2 (en) 2017-04-04
EP1961423A1 (en) 2008-08-27
PL1961423T3 (pl) 2012-09-28
WO2007060278A1 (es) 2007-05-31
BRPI0619353A2 (pt) 2011-09-27

Similar Documents

Publication Publication Date Title
LTPA2018509I1 (lt) Piperazinu pakeisti benzotiofenai, skirti psichikos sutrikimų gydymui
DK1938839T3 (da) Oftalmiske sammensætninger af parasympatiske stimulanter og anti-inflammatoriske midler til anvendelse i behandlingen af presbyopi
CO6210752A2 (es) Compuestos biciclicos y uso como antidiabeticos
DK1900362T3 (da) Alfa-aminoamidderivater anvendelige ved behandlingen af addiktive forstyrrelser
DK3567035T3 (da) N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
DK1727567T3 (da) Aptamer-terapeutiske midler nyttige i behandling af komplementrelaterede forstyrrelser
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
EA201200253A1 (ru) Композиция для лечения муковисцидоза
EA200701995A1 (ru) Способы уменьшения кальцификации
IT1395519B1 (it) Pezzo composito, nonche' impiego del pezzo composito
MA32505B1 (fr) 5-alcynyl-pyrimidines
ATE496924T1 (de) Prodrugs von 5-amino-3-(3'-deoxy-beta-d- ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
TN2011000204A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
BRPI0808043A2 (pt) Compostos tricíclicos úteis no tratamento de distúrbios de ferro.
ATE496913T1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
BRPI0807804A2 (pt) " arilciclopentenos substituídos como agentes terapêuticos ".
CY1111762T1 (el) Διενυδρη παμοϊκη ολανζαπiνη
TW200639155A (en) Thiazolidinones, their production and use as pharmaceutical agents
NO20075662L (no) Roflumilast for behandlingen av pulmonal hypertensjon
ATE527068T1 (de) Mehrteilige walze
DE602008002598D1 (en) Cyclohexylderivate